Member Info for oxygen

Ha, I can easily live without tobacco but it won’t be me who tells the wife that with mineral oil shortages she’ll not be getting any more makeup ! Oil will lubricate the world for many years to come it just will get more expensive as the decades pass.

Will be interesting to see if Medusa do provide any Mfrg capacity, personally doubt it given they’re geared up to produce their own saliva based antibody test which will likely be generating much higher margins albeit a poor substitute against that AVCT will deliver, but ‘joe public’ unfortunately seem to believe the Medusa hype.

It seems for the Brit Awards you’ll need a LFT undertaken within 36 hrs of admission and confirmed as Negative via text msg from NHS Test & Trace. The interesting bit though is PCR testing will also be undertaken , as part of Govt research, before the event so that could highlight a few issues for those using the more dubious LFT’s out there !

Well it really depends upon what valuations they currently place on the Company, but they won’t be too worried about any short term pull back as that should strengthen their case. Unfortunately it seems some of the wild SP predictions seen here are still some way off until a better understanding of the Revenue stream is known. One best to forget for a few months now.

Rarely get timing right but low 15’s was to irresistible !

Now why would we be concerned about the UK when AS has already indicated supply is the issue, not demand. . Like it or not the UK is a fairly small island these days and personally I’d be delighted if he waved two fingers towards PHE .

They can shake it as much as they like but in reality it will only cause more buys. This is one to now tuck away and forget.

‘ Professional use only’ is somewhat meaningless as the Gov’t advice seems to be seek the guidance from a Health care professional eg .pharmacist before us using it. It’s really just a way of protecting Mfrs from legal redress. It certainly won’t impact on sales here.

Ha, yes a mere £100k loss would be worth celebrating, but AB can buy the drinks !

Suspect the main Institutional support will come in the weeks ahead. Lets not forget the Sell Side Analysts aren’t buyers they’re there to recommend the stock to the Buy Side ( who are the real experts ), but irrespective all publicity at this stage is welcome.

Well we certainly deserve a decent price margin for our test over the other one being flogged everywhere. Whilst we’ll never be able to replicate their scale that’s not important when everyone just wants accuracy and is willing to pay that little bit extra for it, especially within the more advanced Nations. At last this will put AVCT’s name on the global stage.

Only moaning that the SP hasn’t gone down as much as would have liked, to add a few more !

Oh dear, I really don’t want to but if this falls much further I’ll be forced to buy substantially more. Suspect the outstanding OO has tempted those with the levers to achieve the price they want, but had to check the price of Brent thinking it may have crashed below $40 !

Also like the fact that GAD/Mologic are equally focused on providing accessible & affordable COVID test kits to some of the poorer regions of the world. Won’t upset me to much if AS tells the UK Govn’t to go swing, given the lack of support provided to date.

For most this news takes away the nervousness in holding the stock so can now relax knowing the future is bright albeit the SP will likely take time to fully reflex valve and that probably needs a wider audience, which AS can use Thurs. to work on !

Well done to the team and interesting that by announcing its launch into Europe would suggest how AS feels about the UK’s lack of support in helping achieve this milestone.

Of course we could all be wrong and only get the Financials plus what’s in the pipeline with AS merely saying CV is still being finalised, given this is largely out of his hands plus we know what the Spanish are like for time keeping !

Not sure why anyone’s expecting any announcement now before Thursday. CV data already received will already have given AS the knowledge he needs and he no longer needs to pander to investors. The Company is on a safe path irrespective, so you either have faith or not. Thurs will be interesting !

I don’t read too much into the separate SSA Meeting, it’s what any Company needs to do and that’s broaden its Institutional basis. Most Retail Investors are short term passengers , usually complain the loudest at AGM’s and just add volatility in the secondary market. It helps to know your place !

Well it is interesting that whilst YE Results aren’t yet time critical, slippage on End Q1. CV results must now be putting pressure on the Company to provide an update. AS will know that any perceived delays, as I suspect there are, won’t go down well and that’s best not communicated in an RNS without detailed explanation , so far better to explain facing your audience and YER gives that opportunity. Irrespective I expect a re rate on Thursday whatever the news as whilst I anticipate a delay we are still on course. Of course would be very happy to be proved wrong with an announcement beforehand !